EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
171 hedge funds and large institutions have $540M invested in Eagle Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
171
Holders Change
+7
Holders Change %
+4.27%
% of All Funds
3.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
66
Reduced
54
Closed
18
Calls
$1.35M
Puts
$16K
Net Calls
+$1.33M
Net Calls Change
+$734K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$16.6M |
| 2 |
BlackRock
New York
|
+$7.57M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$6.28M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.44M |
| 5 |
Morgan Stanley
New York
|
+$4.92M |
